Related Experiment Video
Updated: Sep 4, 2025

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
Published on: April 29, 2022
Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB
Iris E Glykofridis1, Alex A Henneman2, Jesper A Balk1
1Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Human Genetics, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Abstract:
In Birt-Hogg-Dubé (BHD) syndrome, germline loss-of-function mutations in the Folliculin (FLCN) gene lead to an increased risk of renal cancer. To address how FLCN inactivation affects cellular kinase signaling pathways, we analyzed comprehensive phosphoproteomic profiles of FLCNPOS and FLCNNEG human renal tubular epithelial cells (RPTEC/TERT1). In total, 15,744 phosphorylated peptides were identified from 4329 phosphorylated proteins. INKA analysis revealed that FLCN loss alters the activity of numerous kinases, including tyrosine kinases EGFR, MET, and the Ephrin receptor subfamily (EPHA2 and EPHB1), as well their downstream targets MAPK1/3. Validation experiments in the BHD renal tumor cell line UOK257 confirmed that FLCN loss contributes to enhanced MAPK1/3 and downstream RPS6K1/3 signaling. The clinically available MAPK inhibitor Ulixertinib showed enhanced toxicity in FLCNNEG cells. Interestingly, FLCN inactivation induced the phosphorylation of PIK3CD (Tyr524) without altering the phosphorylation of canonical Akt1/Akt2/mTOR/EIF4EBP1 phosphosites. Also, we identified that FLCN inactivation resulted in dephosphorylation of TFEB Ser109, Ser114, and Ser122, which may be linked to increased oxidative stress levels in FLCNNEG cells. Together, our study highlights differential phosphorylation of specific kinases and substrates in FLCNNEG renal cells. This provides insight into BHD-associated renal tumorigenesis and may point to several novel candidates for targeted therapies.
Insights
Loss of the Folliculin (FLCN) gene in Birt-Hogg-Dubé syndrome alters renal cell kinase signaling, impacting pathways like MAPK and PIK3CD. This reveals potential new therapeutic targets for BHD-associated renal cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Birt-Hogg-Dubé (BHD) syndrome is linked to Folliculin (FLCN) gene mutations, increasing renal cancer risk.
- Understanding how FLCN inactivation affects cellular signaling is crucial for BHD pathogenesis research.
Purpose of the Study:
- To investigate the impact of FLCN inactivation on kinase signaling pathways in human renal tubular epithelial cells.
- To identify specific kinases and downstream targets affected by FLCN loss for potential therapeutic strategies.
Main Methods:
- Comprehensive phosphoproteomic profiling of FLCN-positive (FLCNPOS) and FLCN-negative (FLCNNEG) renal cells.
- INKA analysis to identify altered kinase activities and downstream signaling.
- Validation experiments in BHD renal tumor cell lines and assessment of drug sensitivity.
Main Results:
- FLCN loss significantly altered the phosphorylation status of numerous kinases, including EGFR, MET, EPHA2, EPHB1, and MAPK1/3.
- Enhanced MAPK1/3 and RPS6K1/3 signaling was confirmed in FLCN-negative cells, with increased sensitivity to MAPK inhibitor Ulixertinib.
- FLCN inactivation led to PIK3CD phosphorylation and TFEB dephosphorylation, potentially linked to oxidative stress.
Conclusions:
- FLCN inactivation drives differential phosphorylation of specific kinases and substrates in renal cells, contributing to BHD-associated renal tumorigenesis.
- The study identifies novel signaling alterations and potential therapeutic targets, such as MAPK pathway inhibitors, for BHD-related renal cancers.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade

